988 results on '"Lee, Edward B."'
Search Results
52. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
53. Large- Scale Deep Proteomic Analysis in Alzheimer's Disease Brain Regions Across Race and Ethnicity
54. Super-Resolution Imaging Uncovers Nanoscale Tau Aggregate Hyperphosphorylation Patterns in Human Alzheimers Disease Brain Tissue
55. Cytoarchitectonic gradients of laminar degeneration in behavioral variant frontotemporal dementia
56. John Q. Trojanowski: neuropathology icon
57. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
58. Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias
59. Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology
60. Signature laminar distributions of pathology in frontotemporal lobar degeneration
61. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease
62. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
63. TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss
64. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance
65. Correction to: Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration
66. SpaGCN: Integrating gene expression, spatial location and histology to identify spatial domains and spatially variable genes by graph convolutional network
67. TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy
68. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
69. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
70. Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies
71. An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
72. Comparison of histological delineations of medial temporal lobe cortices by four independent neuroanatomy laboratories
73. Neighborhood disadvantage reduces cognitive reserve independent of neuropathologic change
74. Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer's Disease
75. Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease
76. Inferring super-resolution tissue architecture by integrating spatial transcriptomics with histology
77. Automated deep learning segmentation of high-resolution 7 tesla postmortem MRI for quantitative analysis of structure-pathology correlations in neurodegenerative diseases
78. Pathologic burden goes with the flow: MRI perfusion and pathologic burden in frontotemporal lobar degeneration due to tau
79. Tau immunotherapy is associated with glial responses in FTLD-tau
80. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway
81. The continuing legacy of John
82. Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).
83. Multimodal in vivo and postmortem assessments of tau in Lewy body disorders
84. Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies ANTXR2 as a candidate in PLS.
85. Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease.
86. Multisite assessment of NIA‐AA guidelines for the neuropathologic evaluation of Alzheimer's disease
87. Deep clinical and neuropathological phenotyping of Pick disease
88. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
89. Polypathologic associations with grey matter atrophy in neurodegenerative disease
90. C9orf72 proline-arginine dipeptide repeats disrupt the proteasome and perturb proteolytic activities
91. Neurodegenerative Disease Tauopathies
92. Neuroanatomical and cellular degeneration associated with a social disorder characterized by new ritualistic belief systems in a TDP-C patient vs. a Pick patient
93. Modules of genotypic variance reflect heterogeneity across TDP-43 proteinopathies
94. Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy
95. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum
96. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease
97. ADNC-RS, a clinical-genetic risk score, predicts Alzheimer’s pathology in autopsy-confirmed Parkinson’s disease and Dementia with Lewy bodies
98. Retina tissue validation of optical coherence tomography determined outer nuclear layer loss in FTLD-tau
99. Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study
100. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.